• The components of the device are made of hypoallergenic materials that are safe for use as an oral medical device.
• It is commonly very well tolerated.
• Side effects that had been reported were minor, temporary and resolved within three to four weeks.
• Similar observation has been reported in all clinical trials performed so far.
• SomnoGuard is CE marked for OTC distribution in Europe.
• SomnoGuard is US FDA approved for marketing and sale in the United States of America.

Click to Call